HOT AIR BALLOON FLIGHT

News Alert: Pfizer seeks FDA emergency use authorization for its experimental Covid-19 antiviral pill

Pfizer announced Tuesday that it is seeking emergency use authorization from the US Food and Drug Administration for its experimental antiviral Covid-19 pill, known as PF-07321332 or Paxlovid.

The pill is to be administered in combination with an older antiviral drug called ritonavir and is meant to treat mild to moderate Covid-19 in patients at increased risk of hospitalizations or death, the company says.